These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7028634)

  • 1. The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate.
    Greenwood D; Slack RC
    Infection; 1981; 9(5):223-7. PubMed ID: 7028634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology and antibacterial action of methenamine and its salts (mandelate, hippurate and sulfosalicylate).
    Seneca H; Peer P
    Med Times; 1969 Feb; 97(2):243-51. PubMed ID: 5763360
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy reviews: methenamine mandelate and methenamine hippurate.
    Gleckman R; Alvarez S; Joubert DW; Matthews SJ
    Am J Hosp Pharm; 1979 Nov; 36(11):1509-12. PubMed ID: 391033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methenamine and its salts as urinary tract antiseptics: variables affecting the antibacterial activity of formaldehyde, mandelic acid, and hippuric acid in vitro.
    Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1977 Jan; 14(4):287-91. PubMed ID: 13049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formaldehyde generation from methenamine salts in spinal cord injury.
    Devenport JK; Swenson JR; Dukes GE; Sonsalla PK
    Arch Phys Med Rehabil; 1984 May; 65(5):257-9. PubMed ID: 6712452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
    Gow JG
    Practitioner; 1974 Jul; 213(1273):97-101. PubMed ID: 4280569
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activity of methenamine hippurate.
    Katul MJ; Frank IN
    J Urol; 1970 Aug; 104(2):320-4. PubMed ID: 4988650
    [No Abstract]   [Full Text] [Related]  

  • 8. A pH-sensitive methenamine mandelate-loaded nanoparticle induces DNA damage and apoptosis of cancer cells.
    Zhang L; Hao W; Xu L; Gao Y; Wang X; Zhu D; Chen Z; Zhang X; Chen H; Mei L
    Acta Biomater; 2017 Oct; 62():246-256. PubMed ID: 28822844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of urine pH and ascorbic acid on the rate of conversion of methenamine to formaldehyde.
    Strom JG; Jun HW
    Biopharm Drug Dispos; 1993 Jan; 14(1):61-9. PubMed ID: 8427945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of bacteria from urinary tract infections to hexamine mandelate and some common antibiotics.
    Mehrotra GC; Jain K
    J Indian Med Assoc; 1969 Apr; 52(8):386-9. PubMed ID: 5824585
    [No Abstract]   [Full Text] [Related]  

  • 11. Methenamine hippurate in the treatment of urinary tract infections.
    Kasanen A; Mustakallio E; Koskinen EH; Soini V
    Ann Clin Res; 1974 Oct; 6(5):279-84. PubMed ID: 4614694
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of methenamine, methenamine mandelate and methenamine hippurate in pharmaceutical preparations using ion-exchange HPLC.
    Pavitrapok C; Williams DA
    J Pharm Biomed Anal; 2006 Mar; 40(5):1243-8. PubMed ID: 16298099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era.
    Lo TS; Hammer KD; Zegarra M; Cho WC
    Expert Rev Anti Infect Ther; 2014 May; 12(5):549-54. PubMed ID: 24689705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim and methenamine hippurate. A new theoretical combination for the treatment of urinary tract infections.
    Räisänen S; Ylitalo P; Toponen A; Seppänen J
    Scand J Infect Dis; 1985; 17(2):211-8. PubMed ID: 3895402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute porphyrias may be overlooked in patients taking methenamine hippurate.
    Webber PR; Aarsand AK; Sandvik AK; Skadberg Ø; Lindberg M; Sandberg S
    Clin Chem Lab Med; 2010 Sep; 48(9):1355-7. PubMed ID: 20557279
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.
    Cronberg S; Welin CO; Henriksson L; Hellsten S; Persson KM; Stenberg P
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1507-8. PubMed ID: 3111615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of hexamine hippurate and sulphamethizolein patients with indwelling catheters following pelvic-floor surgery.
    Murray CP; Feeney J
    Ir Med J; 1977 Feb; 69(4):97-8. PubMed ID: 852964
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methenamine hippurate VUFB and mandelamine VUFB in the prevention of recurrent dysuria in women].
    Horcicková M; Prát V; Hatala M; Nezádalová E; Milotová Z
    Cas Lek Cesk; 1986 Jul; 125(27):849-53. PubMed ID: 3731221
    [No Abstract]   [Full Text] [Related]  

  • 19. The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate.
    Pearman JW; Peterson GJ; Nash JB
    Invest Urol; 1978 Sep; 16(2):91-8. PubMed ID: 30734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methenamine hippurate (Hiprex).
    Med Lett Drugs Ther; 1968 Jul; 10(15):58-60. PubMed ID: 4875552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.